Myriad Genetics, Inc. (MYGN)
6.045
+0.20
(+3.51%)
USD |
NASDAQ |
Jan 22, 16:00
6.045
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics EPS Diluted (Quarterly): -0.2943 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insulet Corp. | 1.240 |
| Neogen Corp. | -0.0732 |
| ICU Medical, Inc. | -0.1376 |
| Intuitive Surgical, Inc. | 1.947 |
| West Pharmaceutical Services, Inc. | 1.928 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -27.40M |
| Revenue (Quarterly) | 205.70M |
| Total Expenses (Quarterly) | 233.10M |
| Enterprise Value | 611.27M |
| Gross Profit Margin (Quarterly) | 66.07% |
| Profit Margin (Quarterly) | -13.32% |
| Earnings Yield | -71.71% |
| Normalized Earnings Yield | -29.32 |